T cell bispecific antibody for the immune-mediated killing of HER2+ breast cancer cells
Not so long ago, immunotherapy against cancer was positioned as an emerging or even promising treatment, but not one with a proven track record. Today however, novel immunotherapeutics across different tumor types, either ...
Oct 3, 2018
0
128